IGF2BP3 and cancer: However, there are limitations in the study of IGF2BP3 in breast cancer, including a retrospective design that may introduce biases, lack of functional studies on IGF2BP3’s role in cancer progression, limited evidence for its prognostic value, and the relatively small number of positive cases.